If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.40
Bid: 150.00
Ask: 152.00
Change: -1.20 (-0.79%)
Spread: 2.00 (1.333%)
Open: 153.80
High: 154.00
Low: 150.40
Prev. Close: 151.60
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages

12 Oct 2023 14:15

Hardman & Co Research Hardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages 12-Oct-2023 / 14:15 GMT/BST The issuer is solely responsible for the content of this announcement.


 

Analyst interview | Investment Companies

Q&A on Apax Global Alpha (APAX) | Confirming strong underlying competitive advantages

 

Apax Global Alpha is the topic of conversation when Mark Thomas joins DirectorsTalk.

 

In this interview Mark delves into the key theme of his recent report entitled 'Resilience in the face of rising interest rates'. Mark also discusses AGA's strengths, such as its impressive revenue and EBITDA growth, conservative accounting practices, and stable returns from its debt portfolio.

 

Apax Global Alpha (LON:APAX) is a closed-ended investment company that invests in a portfolio of private equity funds advised by Apax, and a focused portfolio of debt and equity.

Listen to the interview: https://www.directorstalkinterviews.com/apax-global-alpha-confirming-strong-underlying-competitive-advantages-video/4121129001?dm_t=0,0,0,0,0

 

If you are interested in meeting the company, you can register your interest here 

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Analyst:

Mark Thomas

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1747833 12-Oct-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
19th Aug 20217:00 amRNS2021 Interim Dividend
19th Aug 20217:00 amRNS2021 Interim Report and Accounts
19th Aug 20217:00 amRNS2021 Interim Results Highlights
5th Aug 20217:00 amRNSApax Funds’ Valuations as at 30 June 2021
4th Aug 20217:00 amRNSApax Funds create social good software platform
22nd Jul 20217:00 amRNSInitial Public Offering of Paycor
14th Jul 20217:00 amRNSFunds advised by Apax announce investment in Tide
6th Jul 20217:00 amRNSIPO of Baltic Classifieds Group
24th Jun 20217:00 amRNSApax Funds announce investment in Revolution Prep
16th Jun 20217:00 amRNSApax Funds invest in CyberGrants
14th Jun 20217:00 amRNSFunds advised by Apax to acquire Infogain
27th May 20217:00 amRNSProposed commitment to Apax Digital Fund II
25th May 20217:00 amRNSFunds advised by Apax invest in Faculty
20th May 20217:00 amRNSResult of secondary placing in Apax Global Alpha
19th May 20214:35 pmRNSSecondary placing of shares in Apax Global Alpha
14th May 20217:00 amRNSFunds advised by Apax to acquire Nulo
14th May 20217:00 amRNSInitial Public Offering of Global-e
5th May 20217:00 amRNSQuarterly results for 31 March 2021
4th May 20215:40 pmRNSResult of AGM
28th Apr 20217:00 amRNSFunds advised by Apax Partners invest in Guesty
26th Mar 20213:05 pmRNSHolding(s) in Company
25th Mar 20217:00 amRNSFunds advised by Apax to acquire Rodenstock Group
19th Mar 20217:00 amRNSResult of secondary placing in Apax Global Alpha
18th Mar 20214:51 pmRNSSecondary placing of shares in Apax Global Alpha
17th Mar 20217:00 amRNSFunds advised by Apax to acquire Lutech
10th Mar 20212:03 pmRNSInitiation research from QuotedData
9th Mar 20215:40 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSInitial Public Offering of InnovAge
2nd Mar 20219:54 amRNS2020 Annual Dividend Declaration
2nd Mar 20217:00 amRNSKey Information Document
2nd Mar 20217:00 amRNSNotice of AGM
2nd Mar 20217:00 amRNS2020 Annual Dividend
2nd Mar 20217:00 amRNS2020 Annual Report and Accounts
2nd Mar 20217:00 amRNS2020 Final Results
15th Feb 202110:45 amRNSDirector Declaration
12th Feb 20217:00 amRNSFunds advised by Apax to acquire Herjavec Group
5th Feb 20217:00 amRNSApax Funds’ Valuations as at 31 December 2020
28th Jan 20217:00 amRNSApax Digital Fund sells stake in Signavio
26th Jan 20217:00 amRNSFunds Advised by Apax acquire PIB Group
19th Jan 202110:30 amRNSAmendment to Revolving Credit Facility
5th Jan 20217:00 amRNSThe Apax Funds sell minority stake in Paycor
29th Dec 20207:00 amRNSFunds Advised by Apax Partners sell Boats Group
29th Dec 20207:00 amRNSFunds Advised by Apax invest in Azentio Software
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20201:43 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSFunds Advised by Apax Partners sell ECI
4th Nov 20207:00 amRNSQuarterly results for 30 September 2020
28th Oct 20207:00 amRNSGenius Sports Group SPAC
22nd Sep 20207:00 amRNSFunds advised by Apax Partners sell Neuraxpharm

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.